ECG Low Ejection Fraction Detection and Guiding in AI Navigated Treatment Era
Launched by NATIONAL DEFENSE MEDICAL CENTER, TAIWAN · May 5, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Outpatients with at least one 12-lead ECG
- • Age between 60-85 years
- Exclusion Criteria:
- • Documented echocardiography within the previous 6 months
- • Known severe LV dysfunction (LVEF \<40%)
- • Known heart failure history
- • Scheduled echocardiography exam
About National Defense Medical Center, Taiwan
The National Defense Medical Center (NDMC) in Taiwan is a premier institution dedicated to advancing military and civilian healthcare through innovative research and clinical trials. As a leading sponsor of clinical studies, NDMC focuses on enhancing medical care for armed forces personnel and the general population by investigating new treatments and therapies. The center fosters collaboration among healthcare professionals, researchers, and military experts to address pressing health issues and improve patient outcomes. With a commitment to ethical standards and scientific excellence, NDMC plays a pivotal role in shaping the future of medical advancements in Taiwan and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported